Amundi Sells 26,199 Shares of Option Care Health, Inc. $OPCH

Amundi cut its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 4.1% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 614,862 shares of the company's stock after selling 26,199 shares during the period. Amundi owned about 0.38% of Option Care Health worth $21,483,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Public Employees Retirement System of Ohio increased its holdings in Option Care Health by 21.6% in the fourth quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock valued at $43,000 after purchasing an additional 332 shares during the period. US Bancorp DE increased its holdings in Option Care Health by 5.0% in the first quarter. US Bancorp DE now owns 8,199 shares of the company's stock valued at $287,000 after purchasing an additional 393 shares during the period. State of Michigan Retirement System increased its holdings in Option Care Health by 1.2% in the first quarter. State of Michigan Retirement System now owns 40,759 shares of the company's stock valued at $1,425,000 after purchasing an additional 500 shares during the period. Louisiana State Employees Retirement System increased its holdings in Option Care Health by 1.1% in the first quarter. Louisiana State Employees Retirement System now owns 47,700 shares of the company's stock valued at $1,667,000 after purchasing an additional 500 shares during the period. Finally, State of Alaska Department of Revenue increased its holdings in Option Care Health by 2.7% in the first quarter. State of Alaska Department of Revenue now owns 19,931 shares of the company's stock valued at $696,000 after purchasing an additional 525 shares during the period. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. acquired 36,000 shares of Option Care Health stock in a transaction on Wednesday, August 20th. The stock was purchased at an average price of $27.15 per share, with a total value of $977,400.00. Following the completion of the purchase, the director owned 375,390 shares of the company's stock, valued at approximately $10,191,838.50. The trade was a 10.61% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Norman L. Wright bought 3,411 shares of the stock in a transaction dated Tuesday, September 9th. The shares were purchased at an average cost of $29.31 per share, for a total transaction of $99,976.41. Following the completion of the transaction, the director directly owned 15,501 shares of the company's stock, valued at $454,334.31. This trade represents a 28.21% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders bought 59,411 shares of company stock valued at $1,627,576 in the last three months. Corporate insiders own 0.64% of the company's stock.

Option Care Health Trading Down 3.0%

OPCH traded down $0.89 during trading on Friday, reaching $28.48. 1,626,043 shares of the stock traded hands, compared to its average volume of 1,842,623. The company has a quick ratio of 1.00, a current ratio of 1.52 and a debt-to-equity ratio of 0.81. The stock has a market capitalization of $4.62 billion, a PE ratio of 22.78, a P/E/G ratio of 1.79 and a beta of 0.82. The stock's 50-day moving average is $29.09 and its 200 day moving average is $31.43. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $35.53.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 EPS for the quarter, beating analysts' consensus estimates of $0.40 by $0.01. The business had revenue of $1.42 billion for the quarter, compared to analysts' expectations of $1.35 billion. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. The business's quarterly revenue was up 15.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.30 earnings per share. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. Equities analysts anticipate that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on the company. Citigroup restated an "outperform" rating on shares of Option Care Health in a report on Thursday, July 31st. JMP Securities increased their price objective on Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a report on Thursday, July 31st. Finally, Barrington Research reaffirmed an "outperform" rating and set a $38.00 price target on shares of Option Care Health in a research report on Thursday, July 10th. Eight equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $35.75.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.